Article Sidebar
Main Article Content
Abstract
Attention-deficit hyperactivity disorder is a biological disease in brain function that is chronic, which results in the function of regulating response and decision making (executive function) not following the child's age development. Pharmacological therapy, especially methylphenidate, is still the primary therapy, even though it is not responsive to drugs. Multimodal therapy is a recommended therapy for ADHD treatment in Europe and the United States, which includes psycho-pharmaceutical therapy, behavioural therapy and family psycho-education. The administration of behaviour therapy alone does not provide satisfactory results, especially for long-term effects. Neurofeedback therapy is a form of behavioural therapy, with the principle of operant conditioning, which aims to train and condition the brain, with feedback from the brain's electrical waves. This paper aims to explain how far the benefits of neurofeedback therapy for people living with ADHD are based on available research data from the latest research results.
Keywords
Article Details
As our aim is to disseminate original research article, hence the publishing right is a necessary one. The publishing right is needed in order to reach the agreement between the author and publisher. As the journal is fully open access, the authors will sign an exclusive license agreement.
The authors have the right to:
- Share their article in the same ways permitted to third parties under the relevant user license.
- Retain copyright, patent, trademark and other intellectual property rights including research data.
- Proper attribution and credit for the published work.
For the open access article, the publisher is granted to the following right.
- The non-exclusive right to publish the article and grant right to others.
- For the published article, the publisher applied for the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
